Alfresa Holdings Corp
TSE:2784
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
2 003.5
2 536
|
Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one Alfresa Holdings Corp stock under the Base Case scenario is 3 749.47 JPY. Compared to the current market price of 2 231.5 JPY, Alfresa Holdings Corp is Undervalued by 40%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Alfresa Holdings Corp
Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
Historical valuation for Alfresa Holdings Corp cannot be conducted due to limitations such as insufficient data or other constraints.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Alfresa Holdings Corp
Balance Sheet Decomposition
Alfresa Holdings Corp
Current Assets | 1.1T |
Cash & Short-Term Investments | 220B |
Receivables | 658.9B |
Other Current Assets | 253B |
Non-Current Assets | 337.2B |
Long-Term Investments | 111.6B |
PP&E | 184.3B |
Intangibles | 16.5B |
Other Non-Current Assets | 24.8B |
Current Liabilities | 928.2B |
Accounts Payable | 874.8B |
Accrued Liabilities | 9.1B |
Other Current Liabilities | 44.4B |
Non-Current Liabilities | 60.5B |
Long-Term Debt | 30B |
Other Non-Current Liabilities | 30.5B |
Earnings Waterfall
Alfresa Holdings Corp
Revenue
|
2.9T
JPY
|
Cost of Revenue
|
-2.7T
JPY
|
Gross Profit
|
209B
JPY
|
Operating Expenses
|
-169.7B
JPY
|
Operating Income
|
39.3B
JPY
|
Other Expenses
|
-9.4B
JPY
|
Net Income
|
29.9B
JPY
|
Free Cash Flow Analysis
Alfresa Holdings Corp
JPY | |
Free Cash Flow | JPY |
Profitability Score
Profitability Due Diligence
Alfresa Holdings Corp's profitability score is 46/100. The higher the profitability score, the more profitable the company is.
Score
Alfresa Holdings Corp's profitability score is 46/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Alfresa Holdings Corp's solvency score is 77/100. The higher the solvency score, the more solvent the company is.
Score
Alfresa Holdings Corp's solvency score is 77/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Alfresa Holdings Corp
According to Wall Street analysts, the average 1-year price target for Alfresa Holdings Corp is 2 342.6 JPY with a low forecast of 2 211.9 JPY and a high forecast of 2 625 JPY.
Dividends
Current shareholder yield for Alfresa Holdings Corp is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Alfresa Holdings Corp. engages in the management of its subsidiaries that deal with wholesaling, manufacturing, import, and export of pharmaceutical products, diagnostic reagents, and medical devices. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 12,045 full-time employees. The company went IPO on 2003-09-29. The firm operates in four business segments. The Pharmaceutical Wholesale segment is engaged in the wholesale of medical products, test reagents, as well as medical equipment and materials. The Self Medication Wholesale segment is engaged in the wholesale of general drugs. The Pharmaceutical Manufacture segment is engaged in the manufacture and sale of pharmaceuticals, test reagents, medical equipment and implements, as well as pharmaceutical powders. The Medical-Related segment is mainly engaged in operation of pharmacies. The others business is engaged in the information system business, the transportation business, the warehousing business, the insurance agency business, the real estate management business, the sale of miscellaneous goods, as well as the manpower dispatching business, among others.
Contact
IPO
Employees
Officers
The intrinsic value of one Alfresa Holdings Corp stock under the Base Case scenario is 3 749.47 JPY.
Compared to the current market price of 2 231.5 JPY, Alfresa Holdings Corp is Undervalued by 40%.